Bifurcation Coronary Lesion 0-0-1
Conditions: Coronary Bifurcation Stenosis
Sponsor: RCF@ICPS

SYNOPSIS 
 
RCF@ICPS 
Coronary bifurcation lesions 0-0-1 SYNOPSIS V2.0 du 16/10/2023 
Page 1 sur 2 
English version 
 
Study Coronary bifurcation lesions 0-0-1 
 
Title and Study Name 
Coronary bifurcation lesions 0-0-1 
 
Study Description 
Observational, non-interventional, retrospective, multicentric, non-randomized registry 
focused on the treatment of bifurcation lesions type 0-0-1 in current practice. 
 
Study Purpose 
To seek a clinical correlation with the angiographic analysis results of different angioplasty 
techniques used for the treatment of type 0-0-1 bifurcation lesions. 
 
Device in Study 
N/A 
 
Number of Patients 
300 patients 
 
Number of Centers 
1. Hôpital Jacques Cartier, Ramsay Général de Santé, Massy, France 
2. Clinique Pasteur, Toulouse, France 
3. Maasstad Hospital, Rotterdam, Netherlands 
 
Study Duration 
Follow-up (at 1 year and at the last possible follow-up) of patients who underwent 
angioplasty for a type 0-0-1 bifurcation lesion between 2016 and 2022. 
 
Follow-up Methods 
Patients will be contacted by phone to assess their clinical status, complications and events, 
examinations, and procedures that occurred after the angioplasty. 
 
Inclusion Criteria 
Any patient: 
- Male or female aged 18 years and older 
- Who underwent angioplasty for a type 0-0-1 coronary bifurcation lesion between 2016 and 
2022 
 
Exclusion Criteria 
Any patient: 
- Opposing the collection and processing of necessary data and refusing additional telephone 
follow-up 

SYNOPSIS 
 
RCF@ICPS 
Coronary bifurcation lesions 0-0-1 SYNOPSIS V2.0 du 16/10/2023 
Page 2 sur 2 
English version 
Primary Objective 
Combined criterion (Major Adverse Cardiac Event) including all-cause mortality, myocardial 
infarction, and target vessel revascularization [TVR]. 
 
Secondary Objectives 
- Separate analysis of mortality, myocardial infarction, and target vessel revascularization 
- Analysis of a clinical evaluation score before and after angioplasty 
 
Clinical Report 
The clinical report of the study will be based on the results at 12 months. 
 
Sponsor 
Dr. Francesca Sanguineti   
Institut Cardiovasculaire Paris Sud   
Hôpital Privé Jacques Cartier   
6 avenue du Noyer Lambert   
91300 Massy, France